Advertisement
Home »

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma.

Aug 14, 2023

ABOUT THE EXPERTS

  • Neetha Parameswaran

    Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

    Liping Luo

    Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

    Lingjun Zhang

    Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

    Joel Chen

    Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

    Frank P DiFilippo

    Department of Nuclear Medicine, Imaging Institute, Cleveland Clinic, Cleveland, OH, USA.

    Charlie Androjna

    Small Animal Imaging, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

    David A Fox

    Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan, Ann Arbor, MI, USA.

    Sarah L Ondrejka

    Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.

    Eric D Hsi

    Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.

    Deepa Jagadeesh

    Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

    Daniel J Lindner

    Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

    Feng Lin

    Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. linf2@ccf.org.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement